Omron Corp. (OTCMKTS:OMRNY) Sees Large Growth in Short Interest

Omron Corp. (OTCMKTS:OMRNY) was the target of a significant growth in short interest in January. As of January 30th, there was short interest totaling 16,138 shares, a growth of 56.0% from the January 15th total of 10,346 shares. Currently, 0.0% of the company’s stock are sold short. Based on an average daily volume of 64,084 shares, the days-to-cover ratio is presently 0.3 days. Based on an average daily volume of 64,084 shares, the days-to-cover ratio is presently 0.3 days. Currently, 0.0% of the company’s stock are sold short.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Omron from a “strong sell” rating to a “hold” rating in a research report on Monday, January 19th. One investment analyst has rated the stock with a Hold rating, Based on data from MarketBeat.com, Omron has a consensus rating of “Hold”.

Institutional Trading of Omron

An institutional investor recently raised its position in Omron stock. GAMMA Investing LLC boosted its holdings in Omron Corp. (OTCMKTS:OMRNY) by 50.7% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,129 shares of the company’s stock after buying an additional 716 shares during the period. GAMMA Investing LLC’s holdings in Omron were worth $54,000 as of its most recent SEC filing. 1.09% of the stock is owned by institutional investors and hedge funds.

Omron Trading Up 0.1%

Shares of OMRNY stock opened at $31.20 on Friday. Omron has a 12 month low of $23.23 and a 12 month high of $32.00. The company has a market cap of $6.43 billion, a PE ratio of 39.49, a price-to-earnings-growth ratio of 0.62 and a beta of 0.98. The company has a quick ratio of 1.40, a current ratio of 2.14 and a debt-to-equity ratio of 0.13. The business’s 50 day moving average is $26.19 and its two-hundred day moving average is $26.56.

Omron (OTCMKTS:OMRNY) last posted its quarterly earnings data on Thursday, February 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.36 by ($0.19). The firm had revenue of $1.41 billion for the quarter, compared to the consensus estimate of $1.38 billion. Omron had a return on equity of 2.46% and a net margin of 2.80%.Omron has set its FY 2025 guidance at 0.960-0.960 EPS. Equities analysts predict that Omron will post 0.42 EPS for the current year.

Omron Company Profile

Omron Corporation (OTCMKTS: OMRNY) is a global leader in automation, sensing, and control technologies. The company designs, manufactures, and sells a wide range of products and solutions for industrial, healthcare and social systems applications. Its core business segments include industrial automation—featuring programmable logic controllers, sensors, relays, servo motors and temperature controllers—and healthcare products such as blood pressure monitors, digital thermometers and nebulizers.

Founded in 1933 by Kazuma Tateishi in Kyoto, Japan, Omron began with the development of the first Japanese automatic timer.